Antidiabetic and neuroprotective effects of a novel repaglinide analog
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Biochemical and Molecular Toxicology"
DOI: 10.1002/jbt.23125
Abstract: Repaglinide (RPG) is an oral insulin secretagogue used in the treatment of diabetes. In this study, a new RPG analog was synthesized. Its antidiabetic and neuroprotective effects on dorsal root ganglions (DRG) in streptozotocin (STZ)‐induced… read more here.
Keywords: diabetic rats; antidiabetic neuroprotective; neuroprotective effects; effects novel ... See more keywords